Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.
Multiple sclerosis and oligodendroglioma: an exceptional association.
Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis.
A controlled trial of natalizumab for relapsing multiple sclerosis.
Protective Associations of HDL with Blood Brain Barrier Injury in Multiple Sclerosis Patients.
Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice.
Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).
Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report.
Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design.
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study.
Ampyra (dalfampridine) medication guide
Evidence-based guideline: Assessment and management of psychiatric disorders in individuals with MS: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24weeks of therapy with subcutaneous interferon beta-1a three times weekly.
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.
Association mapping of disease loci, by use of a pooled DNA genomic screen.
Assessment of confirmed urinary tract infection in patients treated with dalfampridine for multiple sclerosis.
Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis.
Psoriasis during natalizumab treatment for multiple sclerosis.
The environment and disease: association or causation?
Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study.
Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis.
Energy Cost of Walking and Its Association With Gait Parameters, Daily Activity, and Fatigue in Persons With Mild Multiple Sclerosis.
Multiple sclerosis: Risk of comorbid inflammatory diseases in MS might not be genetically determined.
Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: A cross-sectional study.
Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.

Pages